- Home
- MBC vs AMRX Comparison
MBC vs AMRX Comparison
Compare MBC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- AMRX
- Stock Information
- Founded
- MBC 1954
- AMRX 2002
- Country
- MBC United States
- AMRX United States
- Employees
- MBC N/A
- AMRX N/A
- Industry
- MBC Agricultural Chemicals
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- AMRX Health Care
- Exchange
- MBC Nasdaq
- AMRX Nasdaq
- Market Cap
- MBC 2.3B
- AMRX 2.4B
- IPO Year
- MBC N/A
- AMRX N/A
- Fundamental
- Price
- MBC $14.30
- AMRX $7.83
- Analyst Decision
- MBC Strong Buy
- AMRX Strong Buy
- Analyst Count
- MBC 1
- AMRX 5
- Target Price
- MBC $23.00
- AMRX $10.00
- AVG Volume (30 Days)
- MBC 966.8K
- AMRX 979.5K
- Earning Date
- MBC 02-18-2025
- AMRX 02-28-2025
- Dividend Yield
- MBC N/A
- AMRX N/A
- EPS Growth
- MBC N/A
- AMRX N/A
- EPS
- MBC 0.96
- AMRX N/A
- Revenue
- MBC $2,700,400,000.00
- AMRX $2,680,420,000.00
- Revenue This Year
- MBC $2.41
- AMRX $18.06
- Revenue Next Year
- MBC $7.56
- AMRX $3.82
- P/E Ratio
- MBC $15.07
- AMRX N/A
- Revenue Growth
- MBC N/A
- AMRX 12.32
- 52 Week Low
- MBC $13.90
- AMRX $5.01
- 52 Week High
- MBC $20.67
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- MBC 25.84
- AMRX 42.03
- Support Level
- MBC $14.03
- AMRX $7.66
- Resistance Level
- MBC $16.95
- AMRX $7.95
- Average True Range (ATR)
- MBC 0.58
- AMRX 0.21
- MACD
- MBC -0.34
- AMRX -0.03
- Stochastic Oscillator
- MBC 7.48
- AMRX 29.92
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers, and builders.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.